Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

3(42.9%)

N/A

3(42.9%)

Phase 3

1(14.3%)

7Total

Phase 2(3)

N/A(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05832034Phase 2Active Not Recruiting

Add-on Intravenous Immunoglobulins in Early Myositis

Role: collaborator

NCT04647877Phase 2Completed

Phenytoin Cream for the Treatment of Neuropathic Pain

Role: collaborator

NCT05632666Not ApplicableUnknown

Respiratory Muscle Training in Patients With Spinal Muscular Atrophy (SMA).

Role: collaborator

NCT03441347Not ApplicableCompleted

Neuralgic Amyotrophy: Central Reorganization and Rehabilitation After Peripheral Dysfunction

Role: collaborator

NCT02625662Completed

Facioscapulohumeral Dystrophy in Children

Role: collaborator

NCT01336127Not ApplicableCompleted

Effectiveness Study of Occupational Therapy in Parkinson's Disease

Role: collaborator

NCT00136110Phase 3Completed

Trial of Sodium Valproate in Amyotrophic Lateral Sclerosis

Role: collaborator

NCT00272246Phase 2Unknown

Bilateral Internal Pallidum Stimulation in Primary Generalized Dystonia

Role: collaborator

All 8 trials loaded